Measuring oxygen tension modulation, induced by a new pre-radiotherapy therapeutic, in a mammary window chamber mouse model

Rachel Schafer, Arthur F Gmitro

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Tumor regions under hypoxic or low oxygen conditions respond less effectively to many treatment strategies, including radiation therapy. A novel investigational therapeutic, NVX-108 (NuvOx Pharma), has been developed to increase delivery of oxygen through the use of a nano-emulsion of dodecofluoropentane. By raising pO<inf>2</inf> levels prior to delivering radiation, treatment efficacy may be improved. To aid in evaluating the novel drug, oxygen tension was quantitatively measured, spatially and temporally, to record the effect of administrating NVX-108 in an orthotopic mammary window chamber mouse model of breast cancer. The oxygen tension was measured through the use of an oxygen-sensitive coating, comprised of phosphorescent platinum porphyrin dye embedded in a polystyrene matrix. The coating, applied to the surface of the coverslip of the window chamber through spin coating, is placed in contact with the mammary fat pad to record the oxygenation status of the surface tissue layer. Prior to implantation of the window chamber, a tumor is grown in the SCID mouse model by injection of MCF-7 cells into the mammary fat pad. Two-dimensional spatial distributions of the pO<inf>2</inf> levels were obtained through conversion of measured maps of phosphorescent lifetime. The resulting information on the spatial and temporal variation of the induced oxygen modulation could provide valuable insight into the optimal timing between administration of NVX-108 and radiation treatment to provide the most effective treatment outcome.

Original languageEnglish (US)
Title of host publicationProgress in Biomedical Optics and Imaging - Proceedings of SPIE
PublisherSPIE
Volume9328
ISBN (Print)9781628414189
DOIs
StatePublished - 2015
EventImaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XIII - San Francisco, United States
Duration: Feb 9 2015Feb 11 2015

Other

OtherImaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XIII
CountryUnited States
CitySan Francisco
Period2/9/152/11/15

Fingerprint

oxygen tension
Radiotherapy
mice
radiation therapy
Breast
chambers
Modulation
Oxygen
modulation
fats
oxygen
tumors
Oils and fats
coatings
Adipose Tissue
Tumors
oxygenation
radiation
Therapeutics
Fats

Keywords

  • Cancer microenvironment
  • Oxygen Sensing
  • Phosphorescent Lifetime
  • Window Chamber

ASJC Scopus subject areas

  • Atomic and Molecular Physics, and Optics
  • Electronic, Optical and Magnetic Materials
  • Biomaterials
  • Radiology Nuclear Medicine and imaging

Cite this

Schafer, R., & Gmitro, A. F. (2015). Measuring oxygen tension modulation, induced by a new pre-radiotherapy therapeutic, in a mammary window chamber mouse model. In Progress in Biomedical Optics and Imaging - Proceedings of SPIE (Vol. 9328). [932817] SPIE. https://doi.org/10.1117/12.2080236

Measuring oxygen tension modulation, induced by a new pre-radiotherapy therapeutic, in a mammary window chamber mouse model. / Schafer, Rachel; Gmitro, Arthur F.

Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 9328 SPIE, 2015. 932817.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Schafer, R & Gmitro, AF 2015, Measuring oxygen tension modulation, induced by a new pre-radiotherapy therapeutic, in a mammary window chamber mouse model. in Progress in Biomedical Optics and Imaging - Proceedings of SPIE. vol. 9328, 932817, SPIE, Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XIII, San Francisco, United States, 2/9/15. https://doi.org/10.1117/12.2080236
Schafer, Rachel ; Gmitro, Arthur F. / Measuring oxygen tension modulation, induced by a new pre-radiotherapy therapeutic, in a mammary window chamber mouse model. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 9328 SPIE, 2015.
@inproceedings{cfef0818fe094ceaa1b24d980a323864,
title = "Measuring oxygen tension modulation, induced by a new pre-radiotherapy therapeutic, in a mammary window chamber mouse model",
abstract = "Tumor regions under hypoxic or low oxygen conditions respond less effectively to many treatment strategies, including radiation therapy. A novel investigational therapeutic, NVX-108 (NuvOx Pharma), has been developed to increase delivery of oxygen through the use of a nano-emulsion of dodecofluoropentane. By raising pO2 levels prior to delivering radiation, treatment efficacy may be improved. To aid in evaluating the novel drug, oxygen tension was quantitatively measured, spatially and temporally, to record the effect of administrating NVX-108 in an orthotopic mammary window chamber mouse model of breast cancer. The oxygen tension was measured through the use of an oxygen-sensitive coating, comprised of phosphorescent platinum porphyrin dye embedded in a polystyrene matrix. The coating, applied to the surface of the coverslip of the window chamber through spin coating, is placed in contact with the mammary fat pad to record the oxygenation status of the surface tissue layer. Prior to implantation of the window chamber, a tumor is grown in the SCID mouse model by injection of MCF-7 cells into the mammary fat pad. Two-dimensional spatial distributions of the pO2 levels were obtained through conversion of measured maps of phosphorescent lifetime. The resulting information on the spatial and temporal variation of the induced oxygen modulation could provide valuable insight into the optimal timing between administration of NVX-108 and radiation treatment to provide the most effective treatment outcome.",
keywords = "Cancer microenvironment, Oxygen Sensing, Phosphorescent Lifetime, Window Chamber",
author = "Rachel Schafer and Gmitro, {Arthur F}",
year = "2015",
doi = "10.1117/12.2080236",
language = "English (US)",
isbn = "9781628414189",
volume = "9328",
booktitle = "Progress in Biomedical Optics and Imaging - Proceedings of SPIE",
publisher = "SPIE",

}

TY - GEN

T1 - Measuring oxygen tension modulation, induced by a new pre-radiotherapy therapeutic, in a mammary window chamber mouse model

AU - Schafer, Rachel

AU - Gmitro, Arthur F

PY - 2015

Y1 - 2015

N2 - Tumor regions under hypoxic or low oxygen conditions respond less effectively to many treatment strategies, including radiation therapy. A novel investigational therapeutic, NVX-108 (NuvOx Pharma), has been developed to increase delivery of oxygen through the use of a nano-emulsion of dodecofluoropentane. By raising pO2 levels prior to delivering radiation, treatment efficacy may be improved. To aid in evaluating the novel drug, oxygen tension was quantitatively measured, spatially and temporally, to record the effect of administrating NVX-108 in an orthotopic mammary window chamber mouse model of breast cancer. The oxygen tension was measured through the use of an oxygen-sensitive coating, comprised of phosphorescent platinum porphyrin dye embedded in a polystyrene matrix. The coating, applied to the surface of the coverslip of the window chamber through spin coating, is placed in contact with the mammary fat pad to record the oxygenation status of the surface tissue layer. Prior to implantation of the window chamber, a tumor is grown in the SCID mouse model by injection of MCF-7 cells into the mammary fat pad. Two-dimensional spatial distributions of the pO2 levels were obtained through conversion of measured maps of phosphorescent lifetime. The resulting information on the spatial and temporal variation of the induced oxygen modulation could provide valuable insight into the optimal timing between administration of NVX-108 and radiation treatment to provide the most effective treatment outcome.

AB - Tumor regions under hypoxic or low oxygen conditions respond less effectively to many treatment strategies, including radiation therapy. A novel investigational therapeutic, NVX-108 (NuvOx Pharma), has been developed to increase delivery of oxygen through the use of a nano-emulsion of dodecofluoropentane. By raising pO2 levels prior to delivering radiation, treatment efficacy may be improved. To aid in evaluating the novel drug, oxygen tension was quantitatively measured, spatially and temporally, to record the effect of administrating NVX-108 in an orthotopic mammary window chamber mouse model of breast cancer. The oxygen tension was measured through the use of an oxygen-sensitive coating, comprised of phosphorescent platinum porphyrin dye embedded in a polystyrene matrix. The coating, applied to the surface of the coverslip of the window chamber through spin coating, is placed in contact with the mammary fat pad to record the oxygenation status of the surface tissue layer. Prior to implantation of the window chamber, a tumor is grown in the SCID mouse model by injection of MCF-7 cells into the mammary fat pad. Two-dimensional spatial distributions of the pO2 levels were obtained through conversion of measured maps of phosphorescent lifetime. The resulting information on the spatial and temporal variation of the induced oxygen modulation could provide valuable insight into the optimal timing between administration of NVX-108 and radiation treatment to provide the most effective treatment outcome.

KW - Cancer microenvironment

KW - Oxygen Sensing

KW - Phosphorescent Lifetime

KW - Window Chamber

UR - http://www.scopus.com/inward/record.url?scp=84932175927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932175927&partnerID=8YFLogxK

U2 - 10.1117/12.2080236

DO - 10.1117/12.2080236

M3 - Conference contribution

SN - 9781628414189

VL - 9328

BT - Progress in Biomedical Optics and Imaging - Proceedings of SPIE

PB - SPIE

ER -